2025 SID Annual Meeting Coverage: Does Estrogen Therapy Confer a Survival Advantage for Melanoma Patients?
Estrogen therapy may confer a survival benefit in melanoma patients, while combined estrogen and progesterone therapies are associated with increased mortality, results from a large retrospective analysis of patient data show.